4//SEC Filing
Greenhalgh Ellis Skott 4
Accession 0001062993-22-005779
CIK 0001561921other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:10 PM ET
Size
7.0 KB
Accession
0001062993-22-005779
Insider Transaction Report
Form 4
TELA Bio, Inc.TELA
Greenhalgh Ellis Skott
Chief Science Officer
Transactions
- Award
Common Stock
2022-02-23+3,900→ 28,799 total - Award
Stock Option (Right to Buy)
2022-02-23+6,675→ 6,675 totalExercise: $11.75Exp: 2032-02-23→ Common Stock (6,675 underlying)
Footnotes (2)
- [F1]These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
- [F2]The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
Issuer
TELA Bio, Inc.
CIK 0001561921
Entity typeother
Related Parties
1- filerCIK 0001790671
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 5:10 PM ET
- Size
- 7.0 KB